What differs between these two drugs
Tesamorelin vs Sermorelin: What Trials Can Say
Each works through growth hormone your body makes. Their chains and study records differ. No trial has placed one against the other.
What is the main difference between these drugs?
No trial tested these drugs against each other. That's the first limit. Their builds and studies can be compared. They can't be ranked fairly.
Both copy a message made in your brain. Each reaches the gland under your brain. Growth hormone itself isn't in either drug.
Tesamorelin has a 44-amino-acid chain, meaning small protein parts linked together. Its first end was changed. Sermorelin has a shorter 29-amino-acid chain made from similar parts.
Tesamorelin has more modern trial work. FDA approved one HIV use. Sermorelin has an older, different history.
Those facts don't prove either drug is better for you. That answer needs a direct trial.
How do their protein chains differ?
Both drugs reach the same type of gland cell [6][11]. Each causes growth hormone release. That hormone isn't put straight into your body.
Growth hormone then tells your liver to make IGF-1, another hormone made there. The shared route ends there. The drug chains have different lengths.
Tesamorelin is the longer drug [4]. Its changed first end slows breakdown.
Sermorelin keeps the first 29 protein parts. Those parts still carry your brain's message to the gland.
Your body normally cuts such messages apart quickly [6]. Tesamorelin's altered end slows that cutting. The drug gets more time.
Which drug resists breakdown longer?
Tesamorelin's altered end slows your body's cutting [6]. The drug still clears from your blood quickly.
After 26-38 minutes, about half remains. One paper describes removal with a math rate of 1,060 liters an hour [11]. That's an imagined cleared volume, not blood you have or lose.
Sermorelin is shorter. It lacks that altered end. Its action is short too, and studies don't support a stronger claim.
IGF-1 can remain high after tesamorelin clears [11]. That longer blood change supported daily timing in trials.
The mechanism page explains this timing for you. It can't prove which drug works better.
Which drug has more trial evidence?
Tesamorelin has more modern trial work. FDA approved one HIV use in 2010. That approval says nothing about sermorelin.
The approval record includes 3 main reports. Two large trials checked organ fat. Fat fell by 26 weeks. At 52 weeks, it stayed 18% lower [1][2][5].
A separate trial checked liver fat [3]. Another followed healthy men [4]. The 2026 review covered five trials [15].
One review proposed a possible benefit over added growth hormone [6]. It thought using your own hormone might cause fewer unwanted effects. The review didn't test that claim between these drugs. It gave no count of fewer effects.
Sermorelin has an older, different record. It lacks tesamorelin's large organ-fat trials.
This doesn't mean sermorelin fails. It states only what research supports. The shorter chain belongs to sermorelin.
What remains unknown about tesamorelin vs sermorelin?
No controlled trial compared these drugs directly. None asked which removes more organ fat. None asked which raises IGF-1 more.
Their builds can be compared, but that isn't proof. A sound ranking needs a direct trial. Existing research can't close that gap for you.
Both drugs raise growth hormone your body makes. Tesamorelin has approval for only 1 use: excess organ fat from HIV care [5].
Doctors may prescribe tesamorelin for other reasons. FDA hasn't approved those uses. Sport rules forbid both drugs. The side effects and safety page covers tesamorelin alone.